Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus.
Détails
Etat: Public
Version: Final published version
Licence: Non spécifiée
ID Serval
serval:BIB_957BAED3FD8F
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus.
Périodique
Annals of oncology
Collaborateur⸱rice⸱s
Panel members
Contributeur⸱rice⸱s
Addeo A., Albiges L., Ascierto P.A., Banerjee S., Barlesi F., Caldas C., Cardoso F., Cervantes A., Chaberny I.F., Cherny N.I., Choueiri T.K., Chua MLK, Criscitiello C., Curigliano G., de Azambuja E., De Ruysscher D., de Vries E., Dent R., Douillard J.Y., D'Ugo D., Dziadziuszko R., Faivre-Finn C., Felip E., Garassino M., Garrido P., Girard N., Glynne-Jones R., Golfinopoulos V., Haanen J., Hamilton E., Jänne P.A., Jordan K., Kanesvaran R., Kim S.B., Liebert U.G., Lordick F., Machiels J.P., Michielin O., Mok TSK, Morgan G., Obermannova R., Park K., Passaro A., Pentheroudakis G., Peters S., Reck M., Salazar Soler R., Scotté F., Senan S., Sessa C., Smyth E., Soo R., Soria J.C., Spicer J., Strasser F., Tabernero J., Tan DSW, Trapani D., Van Cutsem E., van Halteren H., van Schil P.E., Veronesi G., Yang J.
ISSN
1569-8041 (Electronic)
ISSN-L
0923-7534
Statut éditorial
Publié
Date de publication
10/2020
Peer-reviewed
Oui
Volume
31
Numéro
10
Pages
1320-1335
Langue
anglais
Notes
Publication types: Practice Guideline
Publication Status: ppublish
Publication Status: ppublish
Résumé
We established an international consortium to review and discuss relevant clinical evidence in order to develop expert consensus statements related to cancer management during the severe acute respiratory syndrome coronavirus 2-related disease (COVID-19) pandemic. The steering committee prepared 10 working packages addressing significant clinical questions from diagnosis to surgery. During a virtual consensus meeting of 62 global experts and one patient advocate, led by the European Society for Medical Oncology, statements were discussed, amended and voted upon. When consensus could not be reached, the panel revised statements until a consensus was reached. Overall, the expert panel agreed on 28 consensus statements that can be used to overcome many of the clinical and technical areas of uncertainty ranging from diagnosis to therapeutic planning and treatment during the COVID-19 pandemic.
Mots-clé
Betacoronavirus, Consensus, Coronavirus Infections/epidemiology, Coronavirus Infections/immunology, Coronavirus Infections/therapy, Disease Management, Europe/epidemiology, Granulocyte Colony-Stimulating Factor/pharmacology, Granulocyte Colony-Stimulating Factor/therapeutic use, Humans, Medical Oncology/methods, Medical Oncology/standards, Neoplasms/epidemiology, Neoplasms/immunology, Neoplasms/therapy, Pandemics/prevention & control, Pneumonia, Viral/epidemiology, Pneumonia, Viral/immunology, Pneumonia, Viral/therapy, Real-Time Polymerase Chain Reaction/methods, Real-Time Polymerase Chain Reaction/standards, Societies, Medical/standards, T-Lymphocytes, Cytotoxic/drug effects, T-Lymphocytes, Cytotoxic/immunology, Telemedicine/methods, Telemedicine/standards
Pubmed
Web of science
Open Access
Oui
Création de la notice
13/08/2020 7:32
Dernière modification de la notice
21/11/2022 8:21
Données d'usage
